Philip Sussman
Philip Sussman is a senior-level business development manager with an impressive background in biotechnology and pharmaceuticals. His expertise in financial transactions including private financings and IPO has helped him achieve over $100 million in funding from pharmaceutical company partners. He has worked in various capacities ranging from director to managing partner at BioMed Transition Partners, Thar Pharmaceuticals, Inc., Lesanne Life Sciences, LLC, Perlegen Sciences, Inc., Memory Pharmaceuticals Corporation, and Cadus Pharmaceutical Corporation. His responsibilities included CFO roles, corporate development, and business development and strategy. With a master's degree in biotechnology and another in management-finance from Massachusetts Institute of Technology, he has been able to provide valuable financial and business insights to the companies he has worked with.
